Next Generation Sequencing Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Component, Application, Process, End User, Solutions

Description

The global Next Generation Sequencing Market is projected to grow from $16.1 billion in 2025 to $46.1 billion by 2035, at a compound annual growth rate (CAGR) of 11.1%. The Next Generation Sequencing Market is characterized by a moderately consolidated structure, with sequencing services and sequencing platforms representing the leading segments due to increasing adoption across clinical diagnostics, oncology, drug discovery, and genomic research. The market is driven by declining sequencing costs, technological advancements, and rising demand for precision medicine. Competitive intensity remains high, with major players such as Illumina, Thermo Fisher Scientific, and BGI Group focusing on innovation, partnerships, and portfolio expansion. For instance, in January 2025, Illumina announced a collaboration with NVIDIA to combine sequencing technologies with AI tools for advancing multiomic data analysis and precision health applications.

Based on Type, the Whole Genome Sequencing segment dominated the Next Generation Sequencing Market in 2025, owing to its ability to provide comprehensive genomic insights by analyzing the complete DNA sequence of an organism. Whole genome sequencing is widely adopted across clinical research, rare disease diagnosis, precision medicine, oncology studies, and population genomics due to its high-resolution data generation capability. The segment benefits from declining sequencing costs, improved bioinformatics platforms, and increasing investments in large-scale genomic initiatives. Growing adoption among academic institutions, pharmaceutical companies, and healthcare providers for identifying genetic variations and supporting personalized treatment strategies further reinforces its leading position in the market.

Market Segmentation
Type	Whole Genome Sequencing, Targeted Sequencing, Exome Sequencing, RNA Sequencing, De Novo Sequencing, Epigenomics, Metagenomics, Others
Product	Consumables, Instruments, Software, Others
Services	Sequencing Services, Data Analysis Services, Others
Technology	Sequencing by Synthesis, Ion Semiconductor Sequencing, Single-Molecule Real-Time Sequencing, Nanopore Sequencing, Others
Component	Sample Preparation, Sequencing, Data Analysis, Others
Application	Clinical Investigation, Oncology, Reproductive Health, Agrigenomics, Forensics, Drug Discovery, Others
Process	Library Preparation, Sequencing, Data Processing, Others
End User	Academic & Research Institutions, Pharmaceutical & Biotechnology Companies, Hospitals & Clinics, Others
Solutions	In-House, Outsourced, Others

Based on Application, the Oncology segment is expected to register the fastest growth during the forecast period, driven by the increasing adoption of NGS technologies in cancer diagnosis, biomarker identification, and targeted therapy development. NGS enables comprehensive profiling of tumor genomes, helping clinicians identify actionable mutations and select personalized treatment approaches. The rising prevalence of cancer, expansion of precision oncology programs, and growing use of companion diagnostics are accelerating segment growth. Additionally, collaborations between sequencing companies and pharmaceutical firms for oncology drug development, along with advancements in liquid biopsy and genomic-based cancer monitoring, are expected to further support the rapid expansion of this segment.

Geographical Overview

North America dominated the Next Generation Sequencing (NGS) Market in 2025, supported by advanced healthcare infrastructure, strong genomic research capabilities, and significant investments from pharmaceutical, biotechnology, and academic institutions. The United States remains the leading contributor due to widespread adoption of NGS in oncology, precision medicine, genetic diagnostics, and drug discovery applications. The presence of major sequencing technology providers, well-established research networks, favorable reimbursement frameworks, and continuous government funding for genomics initiatives further strengthens regional demand. Additionally, increasing integration of NGS into clinical workflows and personalized healthcare programs continues to reinforce North America's leading position.

Asia-Pacific is expected to register the fastest growth in the Next Generation Sequencing (NGS) Market during the forecast period, driven by increasing healthcare investments, expanding biotechnology ecosystems, and rising adoption of genomic technologies. Countries such as China, Japan, and India are witnessing rapid development in precision medicine, cancer genomics, and agricultural genomics applications. Government-led genome initiatives, growing research collaborations, and increasing investments in sequencing infrastructure are accelerating market expansion across the region. Furthermore, the rising prevalence of chronic diseases, improving healthcare access, and the growing presence of domestic sequencing companies are creating significant opportunities for NGS adoption in emerging Asian economies.

Key Trends and Drivers

Integration of Artificial Intelligence and Advanced Bioinformatics:

The Next Generation Sequencing (NGS) Market is increasingly adopting artificial intelligence (AI), machine learning, and advanced bioinformatics solutions to enhance genomic data analysis and interpretation. As NGS platforms generate large volumes of complex sequencing data, AI-driven tools are improving variant detection, genome annotation, and predictive analytics, enabling faster and more accurate insights. These advancements are supporting applications in clinical diagnostics, drug discovery, and precision medicine by improving workflow efficiency and reducing analysis complexity. The continued integration of AI with NGS technologies is expected to accelerate innovation and expand the adoption of sequencing solutions across healthcare and research sectors.

Growing Adoption of Precision Medicine and Genomic Diagnostics:

The increasing adoption of precision medicine and genomic diagnostics is a major growth driver for the Next Generation Sequencing (NGS) Market. NGS enables comprehensive analysis of genetic variations, supporting personalized treatment strategies, cancer profiling, rare disease diagnosis, and pharmacogenomics applications. Healthcare providers and pharmaceutical companies are increasingly leveraging sequencing technologies to improve treatment outcomes and accelerate targeted drug development. Rising prevalence of chronic diseases, growing investments in genomic research programs, and increasing integration of sequencing-based diagnostics into clinical workflows are further supporting market expansion. The shift toward personalized healthcare continues to create strong demand for advanced NGS solutions globally.

Research Scope

Estimates and forecasts the overall market size across type, application, and region.
Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

Product Code: GIS10518

1 Executive Summary

1.1 Market Size and Forecast
1.2 Market Overview
1.3 Market Snapshot
1.4 Regional Snapshot
1.5 Strategic Recommendations
1.6 Analyst Notes

2 Market Highlights

2.1 Key Market Highlights by Type
2.2 Key Market Highlights by Product
2.3 Key Market Highlights by Services
2.4 Key Market Highlights by Technology
2.5 Key Market Highlights by Application
2.6 Key Market Highlights by End User
2.7 Key Market Highlights by Component
2.8 Key Market Highlights by Process
2.9 Key Market Highlights by Solutions

3 Market Dynamics

3.1 Macroeconomic Analysis
3.2 Market Trends
3.3 Market Drivers
3.4 Market Opportunities
3.5 Market Restraints
3.6 CAGR Growth Analysis
3.7 Impact Analysis
3.8 Emerging Markets
3.9 Technology Roadmap
3.10 Strategic Frameworks
- 3.10.1 PORTER's 5 Forces Model
- 3.10.2 ANSOFF Matrix
- 3.10.3 4P's Model
- 3.10.4 PESTEL Analysis

4 Segment Analysis

4.1 Market Size & Forecast by Type (2020-2035)
- 4.1.1 Whole Genome Sequencing
- 4.1.2 Targeted Sequencing
- 4.1.3 Exome Sequencing
- 4.1.4 RNA Sequencing
- 4.1.5 De Novo Sequencing
- 4.1.6 Epigenomics
- 4.1.7 Metagenomics
- 4.1.8 Others
4.2 Market Size & Forecast by Product (2020-2035)
- 4.2.1 Consumables
- 4.2.2 Instruments
- 4.2.3 Software
- 4.2.4 Others
4.3 Market Size & Forecast by Services (2020-2035)
- 4.3.1 Sequencing Services
- 4.3.2 Data Analysis Services
- 4.3.3 Others
4.4 Market Size & Forecast by Technology (2020-2035)
- 4.4.1 Sequencing by Synthesis
- 4.4.2 Ion Semiconductor Sequencing
- 4.4.3 Single-Molecule Real-Time Sequencing
- 4.4.4 Nanopore Sequencing
- 4.4.5 Others
4.5 Market Size & Forecast by Application (2020-2035)
- 4.5.1 Clinical Investigation
- 4.5.2 Oncology
- 4.5.3 Reproductive Health
- 4.5.4 Agrigenomics
- 4.5.5 Forensics
- 4.5.6 Drug Discovery
- 4.5.7 Others
4.6 Market Size & Forecast by End User (2020-2035)
- 4.6.1 Academic & Research Institutions
- 4.6.2 Pharmaceutical & Biotechnology Companies
- 4.6.3 Hospitals & Clinics
- 4.6.4 Others
4.7 Market Size & Forecast by Component (2020-2035)
- 4.7.1 Sample Preparation
- 4.7.2 Sequencing
- 4.7.3 Data Analysis
- 4.7.4 Others
4.8 Market Size & Forecast by Process (2020-2035)
- 4.8.1 Library Preparation
- 4.8.2 Sequencing
- 4.8.3 Data Processing
- 4.8.4 Others
4.9 Market Size & Forecast by Solutions (2020-2035)
- 4.9.1 In-House
- 4.9.2 Outsourced
- 4.9.3 Others

5 Regional Analysis

5.1 Global Market Overview
5.2 North America Market Size (2020-2035)
- 5.2.1 United States
  - 5.2.1.1 Type
  - 5.2.1.2 Product
  - 5.2.1.3 Services
  - 5.2.1.4 Technology
  - 5.2.1.5 Application
  - 5.2.1.6 End User
  - 5.2.1.7 Component
  - 5.2.1.8 Process
  - 5.2.1.9 Solutions
- 5.2.2 Canada
  - 5.2.2.1 Type
  - 5.2.2.2 Product
  - 5.2.2.3 Services
  - 5.2.2.4 Technology
  - 5.2.2.5 Application
  - 5.2.2.6 End User
  - 5.2.2.7 Component
  - 5.2.2.8 Process
  - 5.2.2.9 Solutions
- 5.2.3 Mexico
  - 5.2.3.1 Type
  - 5.2.3.2 Product
  - 5.2.3.3 Services
  - 5.2.3.4 Technology
  - 5.2.3.5 Application
  - 5.2.3.6 End User
  - 5.2.3.7 Component
  - 5.2.3.8 Process
  - 5.2.3.9 Solutions
5.3 Latin America Market Size (2020-2035)
- 5.3.1 Brazil
  - 5.3.1.1 Type
  - 5.3.1.2 Product
  - 5.3.1.3 Services
  - 5.3.1.4 Technology
  - 5.3.1.5 Application
  - 5.3.1.6 End User
  - 5.3.1.7 Component
  - 5.3.1.8 Process
  - 5.3.1.9 Solutions
- 5.3.2 Argentina
  - 5.3.2.1 Type
  - 5.3.2.2 Product
  - 5.3.2.3 Services
  - 5.3.2.4 Technology
  - 5.3.2.5 Application
  - 5.3.2.6 End User
  - 5.3.2.7 Component
  - 5.3.2.8 Process
  - 5.3.2.9 Solutions
- 5.3.3 Rest of Latin America
  - 5.3.3.1 Type
  - 5.3.3.2 Product
  - 5.3.3.3 Services
  - 5.3.3.4 Technology
  - 5.3.3.5 Application
  - 5.3.3.6 End User
  - 5.3.3.7 Component
  - 5.3.3.8 Process
  - 5.3.3.9 Solutions
5.4 Asia-Pacific Market Size (2020-2035)
- 5.4.1 China
  - 5.4.1.1 Type
  - 5.4.1.2 Product
  - 5.4.1.3 Services
  - 5.4.1.4 Technology
  - 5.4.1.5 Application
  - 5.4.1.6 End User
  - 5.4.1.7 Component
  - 5.4.1.8 Process
  - 5.4.1.9 Solutions
- 5.4.2 India
  - 5.4.2.1 Type
  - 5.4.2.2 Product
  - 5.4.2.3 Services
  - 5.4.2.4 Technology
  - 5.4.2.5 Application
  - 5.4.2.6 End User
  - 5.4.2.7 Component
  - 5.4.2.8 Process
  - 5.4.2.9 Solutions
- 5.4.3 South Korea
  - 5.4.3.1 Type
  - 5.4.3.2 Product
  - 5.4.3.3 Services
  - 5.4.3.4 Technology
  - 5.4.3.5 Application
  - 5.4.3.6 End User
  - 5.4.3.7 Component
  - 5.4.3.8 Process
  - 5.4.3.9 Solutions
- 5.4.4 Japan
  - 5.4.4.1 Type
  - 5.4.4.2 Product
  - 5.4.4.3 Services
  - 5.4.4.4 Technology
  - 5.4.4.5 Application
  - 5.4.4.6 End User
  - 5.4.4.7 Component
  - 5.4.4.8 Process
  - 5.4.4.9 Solutions
- 5.4.5 Australia
  - 5.4.5.1 Type
  - 5.4.5.2 Product
  - 5.4.5.3 Services
  - 5.4.5.4 Technology
  - 5.4.5.5 Application
  - 5.4.5.6 End User
  - 5.4.5.7 Component
  - 5.4.5.8 Process
  - 5.4.5.9 Solutions
- 5.4.6 Taiwan
  - 5.4.6.1 Type
  - 5.4.6.2 Product
  - 5.4.6.3 Services
  - 5.4.6.4 Technology
  - 5.4.6.5 Application
  - 5.4.6.6 End User
  - 5.4.6.7 Component
  - 5.4.6.8 Process
  - 5.4.6.9 Solutions
- 5.4.7 Rest of APAC
  - 5.4.7.1 Type
  - 5.4.7.2 Product
  - 5.4.7.3 Services
  - 5.4.7.4 Technology
  - 5.4.7.5 Application
  - 5.4.7.6 End User
  - 5.4.7.7 Component
  - 5.4.7.8 Process
  - 5.4.7.9 Solutions
5.5 Europe Market Size (2020-2035)
- 5.5.1 Germany
  - 5.5.1.1 Type
  - 5.5.1.2 Product
  - 5.5.1.3 Services
  - 5.5.1.4 Technology
  - 5.5.1.5 Application
  - 5.5.1.6 End User
  - 5.5.1.7 Component
  - 5.5.1.8 Process
  - 5.5.1.9 Solutions
- 5.5.2 France
  - 5.5.2.1 Type
  - 5.5.2.2 Product
  - 5.5.2.3 Services
  - 5.5.2.4 Technology
  - 5.5.2.5 Application
  - 5.5.2.6 End User
  - 5.5.2.7 Component
  - 5.5.2.8 Process
  - 5.5.2.9 Solutions
- 5.5.3 United Kingdom
  - 5.5.3.1 Type
  - 5.5.3.2 Product
  - 5.5.3.3 Services
  - 5.5.3.4 Technology
  - 5.5.3.5 Application
  - 5.5.3.6 End User
  - 5.5.3.7 Component
  - 5.5.3.8 Process
  - 5.5.3.9 Solutions
- 5.5.4 Spain
  - 5.5.4.1 Type
  - 5.5.4.2 Product
  - 5.5.4.3 Services
  - 5.5.4.4 Technology
  - 5.5.4.5 Application
  - 5.5.4.6 End User
  - 5.5.4.7 Component
  - 5.5.4.8 Process
  - 5.5.4.9 Solutions
- 5.5.5 Italy
  - 5.5.5.1 Type
  - 5.5.5.2 Product
  - 5.5.5.3 Services
  - 5.5.5.4 Technology
  - 5.5.5.5 Application
  - 5.5.5.6 End User
  - 5.5.5.7 Component
  - 5.5.5.8 Process
  - 5.5.5.9 Solutions
- 5.5.6 Rest of Europe
  - 5.5.6.1 Type
  - 5.5.6.2 Product
  - 5.5.6.3 Services
  - 5.5.6.4 Technology
  - 5.5.6.5 Application
  - 5.5.6.6 End User
  - 5.5.6.7 Component
  - 5.5.6.8 Process
  - 5.5.6.9 Solutions
5.6 Middle East & Africa Market Size (2020-2035)
- 5.6.1 Saudi Arabia
  - 5.6.1.1 Type
  - 5.6.1.2 Product
  - 5.6.1.3 Services
  - 5.6.1.4 Technology
  - 5.6.1.5 Application
  - 5.6.1.6 End User
  - 5.6.1.7 Component
  - 5.6.1.8 Process
  - 5.6.1.9 Solutions
- 5.6.2 United Arab Emirates
  - 5.6.2.1 Type
  - 5.6.2.2 Product
  - 5.6.2.3 Services
  - 5.6.2.4 Technology
  - 5.6.2.5 Application
  - 5.6.2.6 End User
  - 5.6.2.7 Component
  - 5.6.2.8 Process
  - 5.6.2.9 Solutions
- 5.6.3 South Africa
  - 5.6.3.1 Type
  - 5.6.3.2 Product
  - 5.6.3.3 Services
  - 5.6.3.4 Technology
  - 5.6.3.5 Application
  - 5.6.3.6 End User
  - 5.6.3.7 Component
  - 5.6.3.8 Process
  - 5.6.3.9 Solutions
- 5.6.4 Sub-Saharan Africa
  - 5.6.4.1 Type
  - 5.6.4.2 Product
  - 5.6.4.3 Services
  - 5.6.4.4 Technology
  - 5.6.4.5 Application
  - 5.6.4.6 End User
  - 5.6.4.7 Component
  - 5.6.4.8 Process
  - 5.6.4.9 Solutions
- 5.6.5 Rest of MEA
  - 5.6.5.1 Type
  - 5.6.5.2 Product
  - 5.6.5.3 Services
  - 5.6.5.4 Technology
  - 5.6.5.5 Application
  - 5.6.5.6 End User
  - 5.6.5.7 Component
  - 5.6.5.8 Process
  - 5.6.5.9 Solutions

6 Market Strategy

6.1 Demand-Supply Gap Analysis
6.2 Trade & Logistics Constraints
6.3 Price-Cost-Margin Trends
6.4 Market Penetration
6.5 Consumer Analysis
6.6 Regulatory Snapshot

7 Competitive Intelligence

7.1 Market Positioning
7.2 Market Share
7.3 Competition Benchmarking
7.4 Top Company Strategies

8 Company Profiles

8.1 Illumina
- 8.1.1 Overview
- 8.1.2 Product Summary
- 8.1.3 Financial Performance
- 8.1.4 SWOT Analysis
8.2 Thermo Fisher Scientific
- 8.2.1 Overview
- 8.2.2 Product Summary
- 8.2.3 Financial Performance
- 8.2.4 SWOT Analysis
8.3 Roche
- 8.3.1 Overview
- 8.3.2 Product Summary
- 8.3.3 Financial Performance
- 8.3.4 SWOT Analysis
8.4 Qiagen
- 8.4.1 Overview
- 8.4.2 Product Summary
- 8.4.3 Financial Performance
- 8.4.4 SWOT Analysis
8.5 Agilent Technologies
- 8.5.1 Overview
- 8.5.2 Product Summary
- 8.5.3 Financial Performance
- 8.5.4 SWOT Analysis
8.6 Pacific Biosciences
- 8.6.1 Overview
- 8.6.2 Product Summary
- 8.6.3 Financial Performance
- 8.6.4 SWOT Analysis
8.7 Oxford Nanopore Technologies
- 8.7.1 Overview
- 8.7.2 Product Summary
- 8.7.3 Financial Performance
- 8.7.4 SWOT Analysis
8.8 BGI Genomics
- 8.8.1 Overview
- 8.8.2 Product Summary
- 8.8.3 Financial Performance
- 8.8.4 SWOT Analysis
8.9 PerkinElmer
- 8.9.1 Overview
- 8.9.2 Product Summary
- 8.9.3 Financial Performance
- 8.9.4 SWOT Analysis
8.10 Bio-Rad Laboratories
- 8.10.1 Overview
- 8.10.2 Product Summary
- 8.10.3 Financial Performance
- 8.10.4 SWOT Analysis
8.11 Genewiz
- 8.11.1 Overview
- 8.11.2 Product Summary
- 8.11.3 Financial Performance
- 8.11.4 SWOT Analysis
8.12 Takara Bio
- 8.12.1 Overview
- 8.12.2 Product Summary
- 8.12.3 Financial Performance
- 8.12.4 SWOT Analysis
8.13 10x Genomics
- 8.13.1 Overview
- 8.13.2 Product Summary
- 8.13.3 Financial Performance
- 8.13.4 SWOT Analysis
8.14 F. Hoffmann-La Roche
- 8.14.1 Overview
- 8.14.2 Product Summary
- 8.14.3 Financial Performance
- 8.14.4 SWOT Analysis
8.15 Eurofins Scientific
- 8.15.1 Overview
- 8.15.2 Product Summary
- 8.15.3 Financial Performance
- 8.15.4 SWOT Analysis
8.16 Macrogen
- 8.16.1 Overview
- 8.16.2 Product Summary
- 8.16.3 Financial Performance
- 8.16.4 SWOT Analysis
8.17 Genomatix
- 8.17.1 Overview
- 8.17.2 Product Summary
- 8.17.3 Financial Performance
- 8.17.4 SWOT Analysis
8.18 GATC Biotech
- 8.18.1 Overview
- 8.18.2 Product Summary
- 8.18.3 Financial Performance
- 8.18.4 SWOT Analysis
8.19 LGC Biosearch Technologies
- 8.19.1 Overview
- 8.19.2 Product Summary
- 8.19.3 Financial Performance
- 8.19.4 SWOT Analysis
8.20 Nugen Technologies
- 8.20.1 Overview
- 8.20.2 Product Summary
- 8.20.3 Financial Performance
- 8.20.4 SWOT Analysis

9 About Us

9.1 About Us
9.2 Research Methodology
9.3 Research Workflow
9.4 Consulting Services
9.5 Our Clients
9.6 Client Testimonials
9.7 Contact Us